Correction to Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer
2012 ◽
Vol 55
(22)
◽
pp. 10314-10314
◽
2012 ◽
Vol 55
(18)
◽
pp. 8091-8109
◽
2016 ◽
Vol 24
(18)
◽
pp. 4281-4290
◽
2011 ◽
Vol 286
(23)
◽
pp. 20666-20676
◽
2015 ◽
Vol 13
(2)
◽
pp. 129-134
◽
Keyword(s):
1990 ◽
Vol 265
(36)
◽
pp. 22255-22261